(Q46827687)

25 December 2017

title

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model (English)

1 reference

25 December 2017

1 reference

Min-De Zeng

1

1 reference

25 December 2017

Lun-Gen Lu

2

1 reference

25 December 2017

Yi-Min Mao

3

1 reference

25 December 2017

De-Kai Qiu

4

1 reference

25 December 2017

Ji-Qiang Li

5

1 reference

25 December 2017

Mo-Bin Wan

6

1 reference

25 December 2017

Cheng-Wei Chen

7

1 reference

25 December 2017

Ji-Yao Wang

8

1 reference

25 December 2017

Xiong Cai

9

1 reference

25 December 2017

Chun-Fang Gao

10

1 reference

25 December 2017

Xia-Qiu Zhou

11

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

published in

Hepatology

1 reference

25 December 2017

volume

42

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1437-1445

1 reference

25 December 2017

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

cites work

1 reference

Hepatitis B virus infection

21 January 2018

1 reference

7 January 2021

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

7 January 2021

Liver fibrosis -- from bench to bedside

1 reference

7 January 2021

Evaluation of liver fibrosis: a concise review

1 reference

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

7 January 2021

The nomenclature of chronic hepatitis: time for a change.

1 reference

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

7 January 2021

Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model

1 reference

7 January 2021

Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements?

1 reference

7 January 2021

Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?

1 reference

7 January 2021

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

7 January 2021

Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis.

1 reference

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Alpha-2-macroglobulin and hepatic fibrosis

1 reference

7 January 2021

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1 reference

7 January 2021

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

1 reference

7 January 2021

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

1 reference

7 January 2021

Natural history of chronic hepatitis B and C.

1 reference

7 January 2021

A comparison of fibrosis progression in chronic liver diseases

1 reference

7 January 2021

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

7 January 2021

Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients

1 reference

7 January 2021

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis

1 reference

7 January 2021

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

7 January 2021

Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

1 reference

7 January 2021

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

7 January 2021

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20960

1 reference

25 December 2017

PubMed ID

16317674

1 reference

25 December 2017